Kursprognose für Jyong Biotech Ltd (MENS)

$1.650

-0.085 (-5.17%)Zum Schluss

Kursprognosen

1-Day Price Prediction

+0.68%

1-Week Prediction

-0.69%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.

Loading chart…

MENS-Prognose durch Analyse ähnlicher Charts

Alphio's MENS stock price prediction model matches the current Jyong Biotech Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.66 (+0.68%). The 1-week path is $1.64 (-0.69%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Soll ich Jyong Biotech Ltd-Aktien kaufen?

Currently, Jyong Biotech Ltd (MENS) is not a strong buy. The stock is trading at $1.87, which is near its 52-week low of $1.43, indicating significant downside risk. The RSI is at 46.062, suggesting it is neither overbought nor oversold, but the stock has a year-to-date change of -45.16%, reflecting ongoing struggles. Additionally, the company has reported substantial losses, with a net income of -3,419,000 USD for Q4 2025, which raises concerns about its financial health. The main risk is the high volatility, with a historical volatility of 80.78%, making it a risky investment for long-term holders.

MENS schloss am Thursday bei $1.65, nachdem der Kurs -5.17% fallen

Jyong Biotech Ltd (MENS) last closed at $1.65, losing -5.17%. These facts feed the 1-day and 1-week MENS price prediction above.

Prognose-Treiber

Die Prognose-Treiber von Jyong Biotech Ltd (MENS) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.

Similar patterns

Negative

Bearish

Seasonality

Positive

Bullish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

Saisonalitätsanalyse für MENS

Historically the probability of a positive November return for MENS is 82.61%. November offers the highest probability of a positive month at 82.61%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…